Identifying medication harm in hospitalised patients: a bimodal, targeted approach
(2020) Therapeutic Advances in Drug Safety — Vol. 11, p. 1-5 (2020)
Files
201215SpinewineAandFalconer-TADS2020.pdf
Open Access - Adobe PDF
- 85.61 KB
Details
- Authors
Falconer, Nazanin 
- Abstract
- (en) Medication harm is in the spotlight with the World Health Organization’s (WHO) Global Patient Safety challenge. Defined as “any negative patient outcome or injury related to a medication”, it is a costly problem for healthcare systems. Mortality, secondary to medication harm, is reported at 0.3% of all hospital patients. Recent local studies in two Australian hospitals linked medication harm to anticoagulants, insulin and antihypertensives, which is similar to findings from other health systems. [...]
- Affiliations
Citations
Falconer, N., Spinewine, A., Doogue, M. P., & Barras, M. (2020). Identifying medication harm in hospitalised patients: a bimodal, targeted approach. Therapeutic Advances in Drug Safety, 11, 1-5. https://doi.org/10.1177/2042098620975516 (Original work published 2020)